Share this:
New cancer clinical trial: PyL in Patients With High Risk and Biochemically Recurrent Prostate Cancer
Published on: January 07, 2021 at 12:00PM
Condition: Prostate Cancer
Intervention: Drug: DCFPyL PET/CT
Sponsor: Hoag Memorial Hospital Presbyterian
Not yet recruiting
https://ift.tt/3hQB4IJ
More Stories
New cancer clinical trial: Cetuximab Sensitivity Correlation Between Patient-Derived Organoids and Clinical Response in Colon Cancer Patients.
New cancer clinical trial: Onco-liq: Kit for Breast Cancer Diagnosis.
New cancer clinical trial: PERformance of Multi-Cancer Early-detectIon Based on Various Biomarkers in fEmale Cancers, PERCEIVE-I